Literature DB >> 19561025

Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities.

Oronzo Catalano1, Serena Antonaci, Guido Moro, Maria Mussida, Mauro Frascaroli, Maurizia Baldi, Franco Cobelli, Paola Baiardi, Janni Nastoli, Raffaella Bloise, Nicola Monteforte, Carlo Napolitano, Silvia G Priori.   

Abstract

AIMS: Recent data suggest that sub-clinical structural abnormalities may be part of the Brugada syndrome (BrS) phenotype, a disease traditionally thought to occur in the structurally normal heart. In this study, we carried out detailed assessment of cardiac morphology and function using cardiac magnetic resonance imaging (CMRI). METHODS AND
RESULTS: Thirty consecutive patients with BrS were compared with 30 sex- (26/4 male/female), body surface area- (+/-0.2 m(2)), and age-matched (+/-5 years) normal volunteers. CMRI exam included long- and short-axis ECG-gated breath-hold morphological T1-TSE sequences for fatty infiltration and cine-SSFP sequences for kinetic assessment. Fatty infiltration was not found in any subject. Patients with BrS compared with normal subjects showed higher incidence of mild right ventricle (RV) wall-motion abnormalities [15 (50%) vs. 5 (17%) subjects (P = 0.006) with reduced radial fractional shortening in more than two segments], reduction of outflow tract ejection fraction (49 +/- 11% vs. 55 +/- 10%; P = 0.032), enlargement of the inflow tract diameter (46 +/- 4 vs. 41 +/- 5 mm, P < 0.001 in short-axis; 46 +/- 4 vs. 42 +/- 5 mm, P = 0.001 in four-chamber long-axis view) and area (22 +/- 2 vs. 20 +/- 3 cm(2); P = 0.050), and of global RV end-systolic volume (34 +/- 10 vs. 30 +/- 6 mL/m(2); P = 0.031) but comparable outflow tract dimensions, global RV end-diastolic volume, left ventricle parameters, and atria areas.
CONCLUSION: CMRI detects a high prevalence of mild structural changes of the RV, and suggests further pathophysiological complexity in BrS. Prospective studies to assess the long-term evolution of such abnormalities are warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19561025     DOI: 10.1093/eurheartj/ehp252

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  45 in total

1.  Evaluation of Brugada syndrome by cardiac magnetic resonance.

Authors:  Carlo Tessa; Jacopo Del Meglio; Andrea Ghidini Ottonelli; Stefano Diciotti; Luca Salvatori; Massimo Magnacca; Marco Chioccioli; Jacopo Lera; Claudio Vignali; Giancarlo Casolo
Journal:  Int J Cardiovasc Imaging       Date:  2012-01-14       Impact factor: 2.357

Review 2.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

Review 3.  Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging.

Authors:  Kristina H Haugaa; Cristina Basso; Luigi P Badano; Chiara Bucciarelli-Ducci; Nuno Cardim; Oliver Gaemperli; Maurizio Galderisi; Gilbert Habib; Juhani Knuuti; Patrizio Lancellotti; William McKenna; Danilo Neglia; Bogdan A Popescu; Thor Edvardsen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-03-01       Impact factor: 6.875

4.  RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome.

Authors:  Nadjet Belbachir; Vincent Portero; Zeina R Al Sayed; Jean-Baptiste Gourraud; Florian Dilasser; Laurence Jesel; Hongchao Guo; Haodi Wu; Nathalie Gaborit; Christophe Guilluy; Aurore Girardeau; Stephanie Bonnaud; Floriane Simonet; Matilde Karakachoff; Sabine Pattier; Carol Scott; Sophie Burel; Céline Marionneau; Caroline Chariau; Anne Gaignerie; Laurent David; Emmanuelle Genin; Jean-François Deleuze; Christian Dina; Vincent Sauzeau; Gervaise Loirand; Isabelle Baró; Jean-Jacques Schott; Vincent Probst; Joseph C Wu; Richard Redon; Flavien Charpentier; Solena Le Scouarnec
Journal:  Eur Heart J       Date:  2019-10-01       Impact factor: 29.983

Review 5.  [Brugada syndrome : Risk stratification and prevention of sudden cardiac death].

Authors:  Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2020-01-31

6.  Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc.

Authors:  Priscila Y Sato; Wanda Coombs; Xianming Lin; Oxana Nekrasova; Kathleen J Green; Lori L Isom; Steven M Taffet; Mario Delmar
Journal:  Circ Res       Date:  2011-05-26       Impact factor: 17.367

Review 7.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

Review 8.  Unmasking the molecular link between arrhythmogenic cardiomyopathy and Brugada syndrome.

Authors:  Javier Moncayo-Arlandi; Ramon Brugada
Journal:  Nat Rev Cardiol       Date:  2017-07-13       Impact factor: 32.419

9.  A new approach for the comparison of conduction abnormality between arrhythmogenic right ventricular cardiomyopathy/dysplasia and Brugada syndrome.

Authors:  Kenji Yodogawa; Norishige Morita; Yoshinori Kobayashi; Hideo Takayama; Toshihiko Ohara; Yoshihiko Seino; Takao Katoh; Kyoichi Mizuno
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

Review 10.  Arrhythmogenic cardiomyopathy and Brugada syndrome: diseases of the connexome.

Authors:  Esperanza Agullo-Pascual; Marina Cerrone; Mario Delmar
Journal:  FEBS Lett       Date:  2014-02-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.